DiagnoCure (TSX: CUR) is a life sciences company commercializing high-value cancer diagnostic tests and lab services that increase clinician and patient confidence in making critical treatment decisions. DiagnoCure’s product offering is focused on molecular tests, which detect irregular gene or protein activity patterns associated with cancer.
Company Details
- Employees
- 13
- Founded
- 1994
- Address
- 4535 Wilfrid-Hamel Blvd, Suite 250,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- diagnocure.com
- Keywords
- Previstage(tm) GCC Colorectal Cancer Staging Test and PCA3 Prostate Cancer Molecular Marker.
- HQ
- Quebec City, Quebec
Diagnocure Inc. Questions
Diagnocure Inc.'s website is diagnocure.com
Diagnocure Inc.'s LinkedIn profile is https://ca.linkedin.com/company/diagnocure
Diagnocure Inc. has
13 employees.
View email and phone details for 13
employees at Diagnocure Inc..
Diagnocure Inc.'s industry is
Biotechnology Research
Diagnocure Inc.'s top competitors are
Momentum Consulting,
Manhattan Growth Partners,
Theradiag Sa.,
Abbott,
Kclassicmedia,
Signal Hill Venture Capital,
Immunoquest Therapeutics,
Dufrane Technologies Llc,
Cen Biotech,
Aspira Women's Health.
Diagnocure Inc.'s categories are Biotechnology Research
Diagnocure Inc.'s founding year is 1994
